COMMUNIQUÉS West-GlobeNewswire

Legend Biotech Expands Scientific Advisory Expertise to Inform Future Growth
04/05/2026
Leading experts across cell therapy, oncology, and immunology will provide strategic input as Legend advances and expands beyond its current portfolio SOMERSET, N.J., May 04, 2026 (GLOBE NEWSWIRE) -- Legend Biotech [...]
Artios Further Expands Leadership Team to Advance Oncology Pipeline and Accelerate Regulatory Execution
04/05/2026
Jeremy B. Fitch, MBA, appointed as Chief Business Officer Michael A. Alrutz, J.D., Ph.D., appointed as General Counsel Guy C. Ruble, PharmD, appointed as VP, Regulatory Affairs CAMBRIDGE, United Kingdom and NEW YORK, [...]
MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
04/05/2026
• MacroGenics receives $60 million cash payment from Sagard Healthcare Partners (Sagard), with the potential to receive an additional near-term sales-based milestone of up to $20 million ROCKVILLE, MD, May 04, 2026 ( [...]
BridgeBio to Present New Acoramidis Data on Disease Progression, Biomarkers, and Clinical Outcomes at ESC-Heart Failure 2026
04/05/2026
PALO ALTO, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- BridgeBio Pharma, Inc. (Nasdaq: BBIO) (“BridgeBio” or the “Company”), a biopharmaceutical company focused on developing medicines for genetic conditions, announced [...]
FibroBiologics Announces Release of CYWC628 Drug Product for Phase 1/2 Diabetic Foot Ulcer Clinical Trial
04/05/2026
HOUSTON, May 04, 2026 (GLOBE NEWSWIRE) -- FibroBiologics, Inc. (Nasdaq: FBLG) (“FibroBiologics”), a clinical-stage biotechnology company with 270+ patents issued and pending with a focus on the development of [...]
After Successful FDA Meeting, Clene Filing Accelerated Approval NDA for ALS
04/05/2026
FDA stated that the “proposed data may be capable of supporting the submission and review of an [NDA] under the accelerated approval pathway” for CNM-Au8 based on neurofilament light (NfL) biomarker data FDA [...]
Abeona Therapeutics® Announces Date of First Quarter Financial Results
04/05/2026
CLEVELAND, May 04, 2026 (GLOBE NEWSWIRE) -- Abeona Therapeutics Inc. (Nasdaq: ABEO) today announced it will host a conference call on Wednesday, May 13, 2026 at 8:30 a.m. ET to discuss its financial results for the [...]
Bicara Therapeutics to Report First Quarter 2026 Financial Results and Business Updates on May 11, 2026, at 8:30 AM ET
04/05/2026
BOSTON, May 04, 2026 (GLOBE NEWSWIRE) -- Bicara Therapeutics Inc. (Nasdaq: BCAX), a clinical-stage biopharmaceutical company committed to bringing transformative bifunctional therapies to patients with solid tumors, [...]
Spur Therapeutics Presents Clinical Insights on Bone Disease Impact of FLT201 in Adults with Gaucher Disease Type 1
04/05/2026
Data presented at IWGGD 2026 Symposium show a meaningful reduction in bone marrow burden with improvements in bone density LONDON, May 04, 2026 (GLOBE NEWSWIRE) -- Spur Therapeutics today released new data from the [...]
4DMT to Participate in Upcoming Investor Conferences
04/05/2026
EMERYVILLE, Calif., May 04, 2026 (GLOBE NEWSWIRE) -- 4D Molecular Therapeutics (Nasdaq: FDMT, 4DMT or the Company), a leading late-stage biotechnology company advancing durable and disease-targeted therapeutics with [...]
Bavarian Nordic – Transactions in Connection with Share Buy-Back Program
04/05/2026
COPENHAGEN, Denmark, May 4, 2026 – Bavarian Nordic A/S (OMX: BAVA) announces transactions under the share buy-back program launched on March 12, 2026, under which the Company will repurchase shares for an amount up to [...]
Mother’s Day Gifting Is Changing: From Symbolic Presents to Meaningful Relief — Bob and Brad Marks the Occasion with Up to 30% Off Wellness Devices
04/05/2026
WINONA, Minn., May 04, 2026 (GLOBE NEWSWIRE) -- Mother’s Day gifting is undergoing a subtle shift, with more consumers moving beyond traditional symbolic presents toward products that offer practical, everyday relief. [...]
Novelty Nobility Taps AGC Biologics to Further Develop Bispecific Drug Candidate
04/05/2026
Successful partnership continues as bispecific antibody candidate moves to GMP manufacturing; project highlights Japan's advanced capabilities in bioprocessing and AGC Biologics' expanding global network CHIBA, Japan, [...]
MemoPryl Gets Reviewed: Complete Formula Evaluation of Ingredient Claims and Side Effects Risk
02/05/2026
MemoPryl Scam Searches, Complaints, and Side Effects Risk Explained for Adults Comparing Nootropic Memory Supplements in 2026 Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been evaluated by the [...]
VisioCore Claims Evaluated: The 8-Second Amazonian Morning Flush For Crystal Clear Vision Support
02/05/2026
VisioCore Vision Support Supplement Ingredients, Lutein and Zeaxanthin Formula, Pricing, Official Website Access, and 60-Day Guarantee Explained for 2026 Aurora, CO, May 02, 2026 (GLOBE NEWSWIRE) -- These statements [...]
Halo Care Skin Tag Remover Claims Evaluated: The Strongest, Most Effective Mole & Skin Tag Corrector Serum
02/05/2026
Halo Care Skin Tag Remover Sanguinaria Canadensis and Zincum Muriaticum Formula Explained: 2026 Pricing, Refund, and Dermatologist Guidance New York, NY, May 02, 2026 (GLOBE NEWSWIRE) -- These statements have not been [...]
Milken Institute Global Conference 2026 Set to Open Tomorrow in Beverly Hills with KFSH Participation
02/05/2026
BEVERLY HILLS, Calif., May 02, 2026 (GLOBE NEWSWIRE) -- The Milken Institute Global Conference 2026 is set to open tomorrow in Beverly Hills, bringing together a global cross section of leaders from healthcare, finance [...]
Avicanna Announces Change in Board of Directors
02/05/2026
TORONTO, May 01, 2026 (GLOBE NEWSWIRE) -- Avicanna Inc. (“ Avicanna ” or the “ Company ) (TSX: AVCN) (OTCQX: AVCNF) (FSE: 0NN) a biopharmaceutical company focused on the development, manufacturing and commercialisation [...]
Avalyn Announces Closing of Initial Public Offering and Full Exercise of Underwriters’ Option to Purchase Additional Shares
01/05/2026
BOSTON, May 01, 2026 (GLOBE NEWSWIRE) -- Avalyn Pharma Inc. (Nasdaq: AVLN), a clinical-stage biopharmaceutical company pioneering inhaled therapies to transform the treatment paradigm of serious, rare respiratory [...]

Pages